Royalty Pharma
RPRX
$30.58
Share price
-1.72%
Change (1 day)
4.57%
Change (1 year)
Categories
Royalty Pharma (RPRX) - Total debt
Total debt on the balance sheet as of December 2024 : $7.61 Billion USD
According to Royalty Pharma's latest financial reports the company's total debt is $7.61 Billion USD. A company’s total debt is the sum of all current and non-current debts.
Royalty Pharma - Total debt on balance sheet (from 2019 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | $7.61 B | 24.08% |
| 2023-12-31 | $6.13 B | -13.79% |
| 2022-12-31 | $7.11 B | 0.29% |
| 2021-12-31 | $7.09 B | 22% |
| 2020-12-31 | $5.81 B | -6.76% |
| 2019-12-31 | $6.23 B | -4.31% |
| 2018-12-31 | $6.51 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | $0.62 B | -91.80% | 🇺🇸 USA |
 | $15.02 B | 97.32% | 🇺🇸 USA |
 | $33.64 B | 341.96% | 🇺🇸 USA |